Back to KROS
DIMENSIONAL FUND ADVISORS LP → KROS
DIMENSIONAL FUND ADVISORS LP KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
19
Latest value
$119K
Q3 2026
Peak value
$4.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $508K |
| Q3 2025 | $17K |
| Q3 2025 | $44K |
| Q4 2025 | $1M |
| Q4 2025 | $104K |
| Q4 2025 | $8K |
| Q4 2025 | $45K |
| Q1 2026 | $3.5M |
| Q1 2026 | $8K |
| Q1 2026 | $23K |
| Q1 2026 | $62K |
| Q2 2026 | $4.5M |
| Q2 2026 | $70K |
| Q2 2026 | $24K |
| Q2 2026 | $308K |
| Q3 2026 | $4.4M |
| Q3 2026 | $98K |
| Q3 2026 | $24K |
| Q3 2026 | $119K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $119K | 10.4K | — | — |
| Q3 2026 | $24K | 2.2K | — | — |
| Q3 2026 | $98K | 8.6K | — | — |
| Q3 2026 | $4.4M | 382.4K | — | — |
| Q2 2026 | $308K | 28.8K | — | — |
| Q2 2026 | $24K | 2.2K | — | — |
| Q2 2026 | $70K | 6.6K | — | — |
| Q2 2026 | $4.5M | 423.0K | — | — |
| Q1 2026 | $62K | 5.6K | — | — |
| Q1 2026 | $23K | 2.2K | — | — |
| Q1 2026 | $8K | 688 | — | — |
| Q1 2026 | $3.5M | 312.9K | — | — |
| Q4 2025 | $45K | 2.2K | — | — |
| Q4 2025 | $8K | 408 | — | — |
| Q4 2025 | $104K | 5.1K | — | — |
| Q4 2025 | $1M | 50.3K | — | — |
| Q3 2025 | $44K | 2.8K | — | — |
| Q3 2025 | $17K | 1.1K | — | — |
| Q3 2025 | $508K | 32.1K | — | — |